Skip to content

Clinical trials

Phase 2 Rectal Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 2 Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20103
20121
20161
20191
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Active, not recruiting3
Completed3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Leiden University Medical Center3
Catharina Ziekenhuis Eindhoven1
Delcath Systems Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Maastricht Radiation Oncology1
Merck KGaA, Darmstadt, Germany1
Pfizer1
Radboud University Medical Center1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms13
Colorectal Neoplasms6
Colonic Neoplasms4
Brain Neoplasms2
Neoplasm Metastasis2
Brain Diseases1
Carcinoma1
Esophageal Neoplasms1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.